Performance of resistant varieties (PIWI) at two different altitudes in Southern Brazil

Autor: de Souza A.L.K., Brighenti A.F., Brighenti E., Caliari V., Stefanini M., Trapp O., Gardin J.P.P., Dalbó M.A., Welter L.J., Camargo S.S.

Publikováno v: BIO Web of Conferences, Vol 12, p 01021 (2019)

In southern Brazil there is a predominance of labrusca and hybrid varieties for wine and juice production due to climatic conditions of high rainfall, temperature and relative humidity. Growing varieties that combine disease resistance and wine quali

Externí odkaz: https://doaj.org/article/a32b87aacac54067b41e56d2467e199c

High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy

Autor: Treré, D., Brighenti, E., Donati, G., Ceccarelli, C., Santini, D., Taffurelli, M., Montanaro, L., Derenzini, M. ^*

Publikováno v: In Annals of Oncology November 2009 20(11):1818-1823

Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.

Autor: Brighenti, E¹, Calabrese, C², Liguori, G², Giannone, F A³, Trerè, D¹, Montanaro, L¹, Derenzini, M¹

Publikováno v: Oncogene. 8/28/2014, Vol. 33 Issue 35, p4396-4406. 11p.

The small molecule CHK1/CHK2 inhibitor PF-0477736 (Pfizer) demonstrates single agent activity in diffuse large B-cell lymphoma

Autor: DERENZINI, ENRICO, IACOBUCCI, ILARIA, Brighenti E, CATTINA, FEDERICA, Casadei B, Davis RE, PILERI, STEFANO, MARTINELLI, GIOVANNI, BACCARANI, MICHELE, ZINZANI, PIER LUIGI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::1e9a765bcec336fcf22ec3cfd25d3eff
http://hdl.handle.net/11585/144075

Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway

Autor: Tavolari S, Bonafé M, Marini M, Ferreri C, Bartolini G, Brighenti E, Manara S, Tomasi V, Laufer S, Guarnieri T.

Publikováno v: Carcinogenesis (N.Y., Print) 29 (2008): 371–380. doi:10.1093/carcin/bgm265
info:cnr-pdr/source/autori:Tavolari S, Bonafé M, Marini M, Ferreri C, Bartolini G, Brighenti E, Manara S, Tomasi V, Laufer S, Guarnieri T./titolo:Licofelone, a dual COX%2F5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway/doi:10.1093%2Fcarcin%2Fbgm265/rivista:Carcinogenesis (N.Y., Print)/anno:2008/pagina_da:371/pagina_a:380/intervallo_pagine:371–380/volume:29

Nowadays, no data are available concerning the potential use of dual cyclooxygenase (COX)/5-lipoxygenase (LOX) inhibitors as anticancer agents in colon cancer treatment. Here, we report, for the first time, that the dual COX/5-LOX inhibitor licofelon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::1b55b3446385fa99c46926f918fd25bf
https://publications.cnr.it/doc/50808